# GSK plc: Form 20-F for the period ended Dec 31, 2019

- Company: [GSK plc](/companies/gsk.md) (CIK 1131399)
- Form: 20-F
- Filed: 2020-03-06
- Accepted by EDGAR: Mar 6, 2020, 21:07 ET
- Period: 2019-12-31
- Accession: 0001193125-20-065064
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1131399/000119312520065064/d769953d20f.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1131399/000119312520065064/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2019-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 12 months, 2019-01-01 to 2019-12-31 | GBP 33.75bn | ifrs-full:Revenue |
| Cost of revenue | 12 months, 2019-01-01 to 2019-12-31 | GBP 11.86bn | ifrs-full:CostOfSales |
| Gross profit | 12 months, 2019-01-01 to 2019-12-31 | GBP 21.89bn | ifrs-full:GrossProfit |
| Operating income | 12 months, 2019-01-01 to 2019-12-31 | GBP 6.96bn | ifrs-full:ProfitLossFromOperatingActivities |
| Income tax | 12 months, 2019-01-01 to 2019-12-31 | GBP 953.0m | ifrs-full:IncomeTaxExpenseContinuingOperations |
| Net income | 12 months, 2019-01-01 to 2019-12-31 | GBP 4.64bn | ifrs-full:ProfitLossAttributableToOwnersOfParent |
| Diluted EPS | 12 months, 2019-01-01 to 2019-12-31 | GBP 0.93 | ifrs-full:DilutedEarningsLossPerShare |
| Basic EPS | 12 months, 2019-01-01 to 2019-12-31 | GBP 0.94 | ifrs-full:BasicEarningsLossPerShare |
| Operating cash flow | 12 months, 2019-01-01 to 2019-12-31 | GBP 8.02bn | ifrs-full:CashFlowsFromUsedInOperatingActivities |
| Capital expenditure | 12 months, 2019-01-01 to 2019-12-31 | GBP 1.26bn | ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities |
| Cash and equivalents | at 2019-12-31 | GBP 4.71bn | ifrs-full:CashAndCashEquivalents |
| Current assets | at 2019-12-31 | GBP 19.49bn | ifrs-full:CurrentAssets |
| Total assets | at 2019-12-31 | GBP 79.69bn | ifrs-full:Assets |
| Current liabilities | at 2019-12-31 | GBP 24.05bn | ifrs-full:CurrentLiabilities |
| Total liabilities | at 2019-12-31 | GBP 61.34bn | ifrs-full:Liabilities |
| Shareholders' equity | at 2019-12-31 | GBP 11.40bn | ifrs-full:EquityAttributableToOwnersOfParent |
| Shares outstanding | at 2019-12-31 | 5,383,102,231 shares | dei:EntityCommonStockSharesOutstanding |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1131399/000119312520065064/d769953d20f.htm

Filed Mar 6, 2020.
Source: SEC EDGAR, the filing index for accession 0001193125-20-065064. Last ingested by Listed: Nov 6, 2026, 12:49 ET. No prices; not investment advice.